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RasGrf1 in longevity studies 
 
In the March issue of Aging, Borras et al. reported that 
RasGrf1  deficiency  delays  aging  in  mice,  with  the 
lifespan of RasGrf1
–/– animals increased by ~20% [1]. 
RasGrf1 is a small GTP exchange factor (GEF) for H-
Ras encoded by the paternally imprinted gene located 
on mouse chromosome 9 and associated with post-natal 
growth  [2].  RasGrf1  is  expressed  in  mouse  in  the 
pancreatic islets and in some regions of the brain (e.g., 
hypothalalmus)  [2],  which  explains  its  role  in  Ras 
activation  in  regulation  of  the  pancreatic  mass  of 
insulin-producing -cells, insulin secretion, and glucose 
homeostasis,  as  well  as  its  involvement  in  some 
neuronal  functions  (e.g.,  an  indirect  effect  on  growth 
hormone  synthesis  and  learning  and  memory).  In   
addition  to   binding   H-Ras,  RasGrf1   shows   other  
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pleiotropic functions after binding to members of the R-
Ras and RAC subfamilies [2].  
 
Several possibilities should be considered in explaining 
how  RasGrf1  deficiency  prolongs  lifespan  in  mice. 
Specifically,  RasGrf1-deficient  mice  display  lower 
levels  of  ROS  and  a  reduction  in  the  parameters  of 
oxidative stress (i.e., glutathione, oxidized protein, and 
malondialdehyde levels), higher levels of sirtuin, and, 
what  is  very  important,  lower  levels  of  circulating 
growth hormone (GH) and insulin/insulin like growth 
factor-1 (IGF-1) in peripheral blood [1]. Thus, in mice, 
RasGrf1 deficiency mimics the caloric restriction (CR) 
pathway, which is well known to have beneficial effects 
in extending lifespan. Evidence is accumulating, based 
on  murine  models  (e.g.,  Laron  dwarf  mutants  and 
normal  mice  under  CR),  for  an  association  between 
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Abstract:  Increase  in  life  span  in  RasGrf1-deficient  mice  revealed  that  RasGrf1  deficiency  promotes  longevity. 
Interestingly, RasGrf1 is one of parentally imprinted genes transcribed from paternally-derived chromosome. Erasure 
of its imprinting results in RasGrf1 downregulation and has been demonstrated in a population of pluripotent adult 
tissues-derived  very  small  embryonic  like  stem  cells  (VSELs),  stem  cells  involved  in  tissue  organ  rejuvenation. 
Furthermore, based on recent observation that RasGrf1 signaling molecule is located downstream from insulin (Ins) 
and insulin like growth factor-1 (Igf-1) receptors, the extended life-span of RasGrf1
-/- mice may support beneficial effect 
of reduced Ins/Igf-1 signaling on longevity. Similarly, downregulation of RasGrf1 in VSELs renders them resistant to 
chronic Ins/Igf-1 signaling and protects from premature depletion from adult tissues. Thus, the studies in RasGrf1
-/- 
mice indicate that some of the imprinted genes may play a role in ontogenetic longevity and suggest that there are sex 
differences in life span that originate at the genome level. All this in toto supports a concept that the sperm genome may 
have a detrimental effect on longevity in mammals. We will discuss a role of RasGrf1 on life span in context of genomic 
imprinting and VSELs. 
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Conversely,  as  reported  for  GH-overexpressing 
transgenic mice that display high levels of circulating 
IGF-1, increased IGF-1 signaling accelerates the aging 
process [5-6]. 
 
Overall, the report by Borras et al. nicely corroborates 
Kono et. al, who reported that bimaternal mice (”sperm 
DNA free-derived mice”) exhibit a life span extended 
by ~30% [7]. These bimaternal mice were artificially 
produced  with  two  sets  of  female  genomes  by 
modulating expression of two paternally imprinted loci: 
insulin-like  growth  factor-2  (IGF-2)-H19  and  Dlk1-
Gtl2, located on chromosomes 7 and 12, respectively. In 
these mice, however, RasGrf1 was repressed and this 
condition,  as  postulated  for  bimaternal  mice  [7]  and 
confirmed now in RasGrf1
–/– mice [1], is presumably a 
cause of their extended lifespan. Moreover, bimaternal 
animals, like RasGrf1
–/– animals, exhibit smaller body 
size,  a  trait  also  observed  in  several  other  long-lived 
mouse  models  (e.g.,  Laron,  Ames,  and  Snell  dwarfs) 
[3]. Based on these reports, RasGrf1 has been identified 
as a gene that may regulate life span in mice. In further 
support of this notion, it is well known that mutations of 
CDC25, a RasGrf1 homolog in yeast [8] or mutations of 
the Ras pathways in C. elegans [9] also lead to extended 
life span. Finally, the RasGrf1 gene has recently been 
found  to  be  associated  with  exceptional  longevity  in 
humans [10]. In sum, all these data have important, and 
not always fully appreciated, implications for parentally 
imprinted genes, including RasGrf1 in mice, that may 
regulate lifespan in mammals. 
 
Parentally imprinted genes and longevity 
 
Genomic  imprinting  is  an  epigenetic  program  that 
results in expression of genes from only one of the two 
parental  chromosomes  [11].  Imprinted  genes  play  a 
crucial  role  in  embryogenesis,  fetal  growth,  the 
totipotential state of the zygote, and the pluripotency of 
developmentally early stem cells. Overall, there are ~80 
imprinted  genes  in  mice  (expressed  from  maternal  or 
paternal chromosomes only) that play a important role 
in embryonic development. Based on the generation of 
the sperm DNA-free bimaternal mice mentioned above, 
a proper imprinting state of Igf-2–H19 and Dlk1-Gtl2 
loci  seems  to  be  crucial  for  initiating  proper 
embryogenesis. 
 
The expression of imprinted genes is regulated by DNA 
methylation  (imprinting)  on  differentially  methylated 
(imprinted) regions (DMRs), which are CpG-rich cis-
elements.  While  almost  all  imprinted  genes  are 
maternally imprinted, there are three known paternally 
imprinted  genes  in  mice,  which  are  Igf-2-H19,  Dlk1-
Gtl2,  and  RasGrf1.  While  paternally  imprinted  genes 
methylated on the haploid set of sperm chromosomes 
(Igf-2-H19,  Dlk1-Gtl2,  and  RasGrf1)  increase  body 
mass and shorten life span, the same genes in a non-
imprinted  state  on  the  haploid  set  of  maternal 
chromosomes in oocytes contribute to smaller body size 
and extended life span. 
 
The proper imprinting of paternal and maternal genes, 
which  are  combined  in  the  zygote  at  the  time  of 
fertilization,  is  required  for  balanced  expression 
(“dosage”)  and  to  initiate  embryogenesis.  During 
development,  all  diploid  somatic  cells  have  a  proper 
imprint imposed on chromosomes inherited from both 
of the parents, except precursors of gametes (primordial 
germ  cells)  that  erase  imprinting  during  their 
developmental migration to the genital ridges [12]. The 
erasure of imprinting makes these cells quiescent and 
prevents  them  from  undergoing  teratoma  formation. 
Imprinting  is  reestablished  in  the  germ  line  after  the 
first meiotic division in precursor cells for sperm and 
oocytes when the chromosomes have been reduced to 
haploid  number.  These  epigenetic  changes  occur  in 
developing  gonads,  indicating  the  influence  of  sex 
hormones,  which  somehow  regulate  imprinting  and 
expression of imprinted genes. 
 
It  is  known  that  erasure  of  genomic  imprint  keeps 
pluripotent stem cells (e.g., primordial germ cells) from 
proliferation and teratoma formation [12]. Differences 
in imprinted genes may also explain why females live 
longer  than  males  in  many  mammalian  species, 
including  humans.  However,  the  reason  why  women 
have an advantage over men with regard to lifespan is 
still  not  fully  clear.  Future  studies  on  sex-related 
epigenetic memory in somatic cells and changes in sex-
dependent expression of imprinted genes may provide 
some clues to this phenomenon. On the other hand, it is 
also well known that  mice cloned from somatic cells 
(e.g.,  by  reproductive  cloning)  have  a  significantly 
shorter lifespan than mice derived from natural mating 
or derived as bimaternal mice by fusion of two female 
gametes. 
 
The  differentially  methylated/imprinted  DMR  for  the 
RasGrf1 gene is located upstream of its promoter, and is 
imprinted/methylated  on  paternal  chromosomes  and 
non-imprinted/non-methylated  on  maternal 
chromosomes.  Methylation  of  this  DMR  prevents 
binding of the insulator protein CTCF to this region. If 
non-methylated,  this  DMR  binds  CTCF,  which 
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is  transcribed  from  the  paternal  chromosome  and  is 
silent on the chromosome from the mother. This leads 
to  the  balanced  “dosage”  of  RasGrf1  expression  in 
diploid  somatic  cells  from  one  of  the  9
th  murine 
chromosomes. Thus, parentally imprinted genes (Igf-2-
H19,  Dlk1-Gtl2,  and  RasGrf1)  seem  to  be  master 
regulators  of  development,  and  evidence  is 
accumulating  that  they  have  also  an  impact  on 
longevity. 
 
The  paternally  imprinted  RasGrf1  gene  regulates 
the number of VSELs 
 
Our interest in RasGrf1 began a few years ago when we 
identified a population of dormant pluripotent stem cells 
in adult murine tissues, including bone marrow (BM), 
that  we  named  very  small  embryonic-like  stem  cells 
(VSELs). Murine BM-derived VSELs: i) are very rare 
(~0.01% of nucleated BM cells); ii) are small in size 
(~3–5  m);  iii)  express  several  pluripotent  stem  cell 
(PSC) markers, such as Oct4, Nanog, Rex-1, and SSEA-
1;  iv)  possess  large  nuclei  containing  unorganized 
chromatin  (euchromatin);  and  v)  are  capable  of 
differentiation into cells from all three germ lineages in 
vitro. Furthermore, VSELs exhibit a significantly higher 
nuclear/cytoplasm (N/C) ratio and a lower cytoplasmic 
area compared to HSCs. We have already confirmed the 
true  expression  of  Oct4  and  Nanog  in  BM-derived 
VSELs  by  demonstrating  an  unmethylated, 
transcriptionally  active  open  chromatin  structure  for 
both the Oct4 and Nanog promoters [13] in these cells. 
 
 
 
 
 
 
 
 
 
We  have  postulated  that  these  cells  are  a  backup 
population of PSCs that supplies stem cells committed 
to particular tissues and thus plays a role in regeneration 
and  rejuvenation  of  adult  tissues.  As  we  have 
demonstrated  in  BM,  VSELs  are  precursor  cells  for 
hematopoietic stem cells (HSCs). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
We  have  recently  identified  a  crucial  genomic 
imprinting-related  epigenetic  mechanism  that  governs 
the VSEL quiescent state, preventing their proliferation 
and  the  spontaneous  growth  of  teratomas  [13].  This 
mechanism  is  based  on  the  epigenetic  changes  in 
selected  somatic-imprinted  genes  (i.e.,  Igf-2-H19, 
RasGRF1,  and  IGF-2R)  that  are  involved  in  insulin 
(Ins)  and  insulin-like  growth  factor  signaling  (IGF-1 
and  IGF-2).  By  erasing  paternal  imprints,  VSELs 
downregulate expression of IGF-2, which seems to be 
an autocrine growth factor for these cells. Additionally, 
Ins/Igf signaling in VSELs is impaired due to erasure of 
the  paternal  imprinting  of  the  RasGrf1  gene,  which 
represses its expression. In support of this notion, we 
observed  that  in  embryonic  stem  cells,  RasGrf1  is 
indeed the downstream signaling protein for activated 
insulin and insulin growth factor-1 receptors (Figure 1). 
Furthermore,  in  addition  to  perturbed  imprinting  of 
paternally  imprinted  genes  in  VSELs,  some  of  the 
maternally  imprinted  genes  become,  by  contrast, 
Figure 1. RasGrf1 phosporylation in murine embryonic ES-D3 
cells.  Panel  A.  RasGrf1  protein  phophorylation  at  Ser929  was 
detected by western blot after stimulation for 5 min with LIF (50 
ng/mL),  insulin  (10 ng/mL),  IGF-1  (100 ng/mL),  and  IGF-2  (100 
ng/ml).  Panel  B.  The  total  level  of  Ras-Grf1  protein.  The 
experiment was repeated twice with similar results. 
Figure 2. Insulin/IGF-1 and -2 signaling and imprinted genes. In 
mammals, there are three insulin factors (insulin, IGF-1, and IGF-
2) that bind to two tyrosine kinase receptors, insulin receptor 
(InsR),  and  IGF-1  receptor  (IGF-1R).  Igf2R  is  a  non-signaling 
mannose-type sink receptor for IGF-2. Depending on cell type, 
activation of InsR and IGF-1R lead to metabolic and proliferative 
responses. RasGrf1 is a small GTP exchange factor (GEF) and is 
involved in signaling from InsR and IGF-1R. VSELs, due to changes 
in  the  epigenetic  state  of  parentally  imprinted  genes,  show  a 
decrease  in  Igf-2  and  RasGrf1  expression  (green)  and  Igf2R 
overexpression  (red).  These  epigenetic  changes  in  genes 
regulating  insulin/Igf  signaling  keep  VSELs  quiescent  in  adult 
tissues.  We  hypothesize  that  chronic  exposure  to  Ins/Igf 
accelerates  premature  depletion  of  VSELs,  while  RasGrf1 
deficiency has the opposite effect. 
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receptor (IGF-2R), which serves as a molecular sink for 
IGF-2 and prevents its interaction with IGF-1 receptor 
(IGF-1R)  [12].  The  involvement  of  these  paternally 
imprinted (Igf-2 and RasGrf1) and maternally imprinted 
(IGF-2R) genes in insulin and insulin-like growth factor 
signaling is depicted schematically in Figure 2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thus,  impaired  signaling  from  IGF-1R  and  InsR  is 
responsible  for  keeping  VSELs  quiescent  in  adult 
tissues.  It  is  well  known  that  changes  in  Ins/Igf 
signaling  have  important  implications  for  aging.  As 
mentioned above i) IGF-1 signaling negatively regulates 
lifespan  in  worms,  flies,  and  mammals  and  ii)  IGF-1 
and  insulin  level  in  blood  is  positively  regulated  by 
caloric  uptake  [4].  We  hypothesize  that  chronic 
stimulation over time with insulin and IGF-1 leads to 
accelerated depletion of these cells in tissues [12]. We 
have demonstrated that the number of VSELs decreases 
with age in mice and correlates with their senescence 
[12], which could explain the aging process at the level 
of the PSCs residing in adult tissues (VSELs) [12]. A 
decrease  in  the  number  of  these  cells  would  directly 
impact the regenerative capacity of their progeny, the 
pool  of  tissue-committed  stem  cells  that  are  more 
restricted in their ability to differentiate. 
 
In  fact,  our  studies  performed  on  normal  young  (4-
week-old) and old (2-year-old) mice revealed that the 
number  of  VSELs  and  their  pluripotency  decreases 
during  ageing  [14].  Accordingly,  VSELs  from  young 
mice show erasure of DMRs for Igf-2-H19 and RasGrf1 
loci and thus do not express IGF-2 and RasGrf1 (Figure 
3 panel A). In contrast, VSELs from old mice show the 
somatic  type  of  methylation  at  both  Igf2-H19  and 
RasGRF1 loci, which increases expression of Igf-2 and 
RasGrf1  and,  thus,  their  sensitivity  to  insulin  factor 
signaling (Figure 3 panel A). This suggests that chronic 
Ins/Igf  signaling  via  RasGrf1  may  contribute  to  age-
related depletion of VSELs and the senescence process. 
This  in  parallel  corresponds  with  changes  that  lower 
expression of the pluripotency master-regulators, such 
as  Oct4,  Nanog,  Sox2,  Klf4,  and  cMyc.  At  the 
molecular  level,  the  Oct4  promoter  in  VSELs  as  we 
have demonstrated becomes gradually hypermethylated 
with age and shows a closed chromatin structure [14]. 
 
Further evidence for the role of VSELs and imprinted 
genes  on  lifespan  comes  from  our  recent  studies  on 
murine models of longevity [15]. We observed that the 
number  of  VSELs  in  BM  positively  correlates  with 
extended  lifespan  and  both  parameters  are  negatively 
affected  by  plasma  IGF-1  level.  In  support  of  this 
observation, while long-living Laron dwarf mice with 
low circulating plasma IGF-1 levels have a significantly 
higher number of VSELs at age 2 years compared to 
their wild type (wt) littermates [14], short-living bovine 
GH-overexpressing transgenic mice with high levels of 
circulating IGF-1 display a reduced number of VSELs 
at age 6 months [15]. These changes in the number of 
VSELs were correlated with hypomethylation of DMRs 
at the Igf-2-H19 and RasGrf1 loci in Laron dwarfs and 
hypermethylation  of  these  loci  in  GH-transgenic 
animals  ([14,  15]  and  Figure  3  panel  B).  The 
corresponding reduction in VSEL number and increased 
hypermethylation of DMRs for Igf-2-H19 and RasGrf1 
loci  and  expression  of  these  genes  was  recently 
Figure 3. The change of genomic imprinting during VSEL ageing. 
Panel A. RQ-PCR analysis of RasGrf1, Igf2, and H19 expression in 
VSELs isolated from 4-week-old and 18-month-old C57BL/6 mice. 
The relative expression level was represented as the percentage 
of 2 microglobin (2mg) expression and shown as the mean  
SD.  Please  note  reciprocal  expression  in  Igf-2  (that  promotes 
proliferation)  and  H19  (that  encodes  for  mRNA  giving  rise  to 
several  miRNA  negatively  affecting  cell  proliferation).  Both  of 
these genes (Igf2-H19) are regulated in tandem by a common 
DMR that affects their expression – when one is silenced another 
one  is  upregulated.  Panel  B.  Combined  bisulfate-restriction 
analysis  (COBRA)  assay  of  Igf2-H19  DMR1  (upper  panel)  and 
RasGrf1  DMR  (lower  panel)  by  BstUI  restriction  enzyme  in  6-
month-old control wild type (WT) and 6-month-old transgenic 
bovine GH-overexpressing mice (bGH-TG). The COBRA assay was 
performed on VSELs, hematopoietic stem cells (HSC), and bone 
marrow  mononuclear  cells  (BMMNC).  "–"  indicates  bisulfate 
modification  was  not  performed  on  the  DNA  (control);  "+" 
indicates that DNA was subjected to bisulfate modification. The 
unmethylated  DNA  (uMe)  was  not  cleaved,  in  contrast  to 
methylated DNA (Me), because of a sequence change at the site 
recognized by a restriction enzyme after bisulfite reaction. *non-
specific. 
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with GH or IGF-1 (submitted for publication). 
 
Based on these data, we proposed that epiblast-derived 
VSELs,  which  are  deposited  in  adult  tissues  as  a 
population  of  most-primitive  stem  cells  involved  in 
tissue/organ  rejuvenation,  are  depleted  by  chronic 
Ins/Igf signaling. Prolonged signaling by insulin, IGF-1, 
and IGF-2 (e.g., due to high caloric uptake or as a result 
of  GH  overexpression  in  bGH  transgenic  mice)  may 
lead  to  premature  depletion  of  these  cells  in  tissues. 
BM-residing VSELs are a backup population for HSCs 
and  a  decrease  in  the  number  of  VSELs  in  BM  will 
directly affect the pool of these cells. Further studies are 
required to see whether similar scenarios occur in other 
cases of tissue-committed stem cells (e.g., mesenchymal 
stem  cells  or  satellite  stem  cells).  A  reverse 
phenomenon  occurs  in  attenuated  insulin,  IGF-1,  and 
IGF-2 signaling (e.g., due to caloric restriction, GHR 
mutations,  or  RasGrf1
–/–  mice)  where  VSELs  are 
protected  from  uncontrolled  premature  depletion.  We 
hypothesize that while the activation of VSELs occurs 
via very finely tuned and controlled signals (e.g., bone 
morphogenic  protein  levels),  uncontrolled  and 
prolonged  Ins/Igf  signaling  depletes  these  cells  and, 
more importantly, may put them in danger of becoming 
cancer  stem  cell  precursors.  In  fact,  animals  with 
enhanced Ins/Igf signaling have a much higher risk of 
tumor formation [5] compared, for example, to Laron 
dwarf mice or Laron dwarf patients, which have very 
low levels of circulating IGF-1 and are highly resistant 
to development of neoplastic diseases [3, 16]. 
 
CONCLUSIONS 
 
In  conclusion,  longevity  studies  in  RasGrf1-deficient 
mice have demonstrated indirectly that imprinted genes 
play  a  crucial  role  in  ontogenetic  longevity.  These 
studies  also  suggest  that  there  are  sex  differences  in 
longevity that originate at the genome level, implying 
that  the  sperm  genome  has  a  detrimental  effect  on 
longevity  in  mammals.  It  will  be  interesting  to  see 
whether  RasGrf1-overexpressing  mice  display  a 
shortened  lifespan  and  whether  small  molecule 
inhibitors of Ras signaling will have beneficial effects 
on longevity in  mice and perhaps humans as well.  It 
would  also  be  interesting  to  measure  directly  the 
number of VSELs and the state of parentally imprinted 
genes  both  in  RasGrf1
–/–  and  RasGrf1-overexpressing 
mice.  In  sum,  longevity  studies  have  increased  in 
sophistication to the point where explanations can now 
be sought at the level of imprinted genes, which are the 
master regulators of development, and their epigenetic 
regulation. 
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